Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'CARBOPLATIN' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 1778 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Huitema, ADR; Mathot, RAA; Tibben, MM; Rodenhuis, S; Beijnen, JH
      A mechanism-based pharmacokinetic model for the cytochrome P450 drug-drug interaction between cyclophosphamide and thioTEPA and the autoinduction of cyclophosphamide

      JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS
    2. Greco, FA; Gray, J; Burris, HA; Erland, JB; Morrissey, LH; Hainsworth, JD
      Taxane-based chemotherapy for patients with carcinoma of unknown primary site

      CANCER JOURNAL
    3. Liu, Q; Zhang, JY; Ke, XK; Mei, YH; Zhu, LG; Guo, ZJ
      ESMS and NMR investigations on the interaction of the anticancer drug cisplatin and chemopreventive agent selenomethionine

      JOURNAL OF THE CHEMICAL SOCIETY-DALTON TRANSACTIONS
    4. Fraenkel, R; Freeman, S; Sohmer, H
      The effect of various durations of noise exposure on auditory brainstem response, distortion product otoacoustic emissions and transient evoked otoacoustic emissions in rats

      AUDIOLOGY AND NEURO-OTOLOGY
    5. Zufia, L; Aldaz, A; Castellanos, C; Giraldez, J
      Simple and rapid determination of carboplatin in plasma by highperformanceliquid chromatography. Error pattern and application to clinical pharmacokinetic studies

      JOURNAL OF CHROMATOGRAPHY B
    6. Barefoot, RR
      Speciation of platinum compounds: a review of recent applications in studies of platinum anticancer drugs

      JOURNAL OF CHROMATOGRAPHY B
    7. Jelic, S; Babovic, N; Stamatovic, L; Kreacic, M; Matkovic, S; Popov, I
      Vinblastin-carboplatin for metastatic cutaneous melanoma as first-line chemotherapy and in dacarbazine failures - A single-center study

      MEDICAL ONCOLOGY
    8. Kosmas, C; Tsavaris, NB; Vadiaka, M; Chiras, T; Boletis, J; Kostakis, A
      Extragonadal seminoma after renal transplantation and immunosuppression; Treatment in the presence of renal dysfunction - A case report and literature review

      MEDICAL ONCOLOGY
    9. Harries, M; Kaye, SB
      Recent advances in the treatment of epithelial ovarian cancer

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    10. Wadler, S
      New developments in the treatment of ovarian cancer

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    11. Cuomo, AM; Della Cuna, FSR; Baiardi, P; Torazzo, R; Preti, P; Della Cuna, GR
      Three conventional-drug combination (ifosfamide, carboplatin, etoposide-ICE regimen) in advanced non-small cell lung cancer (NSCLC)

      JOURNAL OF CHEMOTHERAPY
    12. Bayley, A; Warde, P; Milosevic, M; Gospodarowicz, M
      Surveillance for stage I testicular seminoma: a review

      UROLOGIC ONCOLOGY
    13. Veal, GJ; Dias, C; Price, L; Parry, A; Errington, J; Hale, J; Pearson, ADJ; Boddy, AV; Newell, DR; Tilby, MJ
      Influence of cellular factors and pharmacokinetics on the formation of platinum-DNA adducts in leukocytes of children receiving cisplatin therapy

      CLINICAL CANCER RESEARCH
    14. Smith, MA; Anderson, B
      Phase II window studies: 10 years of experience and counting

      JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
    15. Ferguson, WS; Harris, MB; Goorin, AM; Gebhardt, MC; Link, MP; Shochat, SJ; Siegal, GP; Devidas, M; Grier, HE
      Presurgical window of carboplatin and surgery and multidrug chemotherapy for the treatment of newly diagnosed metastatic or unresectable osteosarcoma: Pediatric Oncology Group trial

      JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
    16. Yu, DY; Dahl, GVH; Shames, RS; Fisher, PG
      Weekly dosing of carboplatin increases risk of allergy in children

      JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
    17. Goldman, SC; Bracho, F; Davenport, V; Slack, R; Areman, E; Shen, V; Lenarsky, C; Weinthal, J; Hughes, R; Cairo, MS
      Feasibility study of IL-11 and granulocyte colony-stimulating factor aftermyelosuppressive chemotherapy to mobilize peripheral blood stem cells fromheavily pretreated patients

      JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
    18. Cairo, MS; Shen, V; Krailo, MD; Bauer, M; Miser, JS; Sato, JK; Blatt, J; Blazar, BR; Frierdich, S; Liu-Mares, W; Reaman, GH
      Prospective randomized trial between two doses of granulocyte colony-stimulating factor after ifosfamide, carboplatin, and etoposide in children withrecurrent or refractory solid tumors: A Children's Cancer Group report

      JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
    19. Wanebo, H; Chougule, P; Ready, N; Safran, H; Ackerley, W; Koness, RJ; McRae, R; Nigri, P; Leone, L; Radie-Keane, K; Reiss, P; Kennedy, T
      Surgical resection is necessary to maximize tumor control in function-preserving, aggressive chemoradiation protocols for advanced squamous cancer ofthe head and neck (stage III and IV)

      ANNALS OF SURGICAL ONCOLOGY
    20. Kintzel, PE
      Prophylaxis for paclitaxel hypersensitivity reactions

      ANNALS OF PHARMACOTHERAPY
    21. Lesser, GJ
      Chemotherapy of low-grade gliomas

      SEMINARS IN RADIATION ONCOLOGY
    22. Wu, CH; Yang, CH; Lee, JN; Hsu, SC; Tsai, EM
      Weekly and monthly regimens of paclitaxel and carboplatin in the management of advanced ovarian cancer. A preliminary report on side effects

      INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
    23. Vermorken, JB
      The integration of paclitaxel and new platinum compounds in the treatment of advanced ovarian cancer

      INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
    24. Bookman, MA
      Developmental chemotherapy in advanced ovarian cancer: Incorporation of topoisomerase-I inhibitors and perspective of the Gynecologic Oncology Group

      INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
    25. Pujade-Lauraine, E; Cure, H; Battista, C; Guastalla, JP; Chiurazzi, B; Fabbro, M; Tubiana-Mathieu, N; Bourgeois, H; Lioure, B; Paraiso, D; Lotz, JP
      High dose chemotherapy in ovarian cancer

      INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
    26. Airoldi, M; De Crescenzo, A; Pedani, F; Marchionatti, S; Gabriele, AM; Succo, G; Rosti, G; Bumma, C
      Feasibility and long-term results of autologous PBSC transplantation in recurrent undifferentiated nasopharyngeal carcinoma

      HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
    27. Gaspar, LE
      Optimizing chemoradiation therapy approaches to unresectable stage III non-small cell lung cancer

      CURRENT OPINION IN ONCOLOGY
    28. Markman, M
      Intraperitoneal chemotherapy is appropriate first line therapy for patients with optimally debulked ovarian cancer

      CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
    29. Chiara, S; Lionetto, R; Vincenti, M; Bruzzone, M; Nobile, MT; Gadducci, A; Carnino, F; Rosso, R; Conte, P
      Advanced ovarian cancer in the elderly: results of consecutive trials withcisplatin-based chemotherapy

      CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
    30. Flechon, A; Culine, S; Droz, JP
      Intensive and timely chemotherapy, the key of success in testicular cancer

      CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
    31. Pinguet, F; Savelli, K; Petit, I; Gerbi-Benmansour, Y; Fabbro, M
      Pharmaco-economic study of intensive chemotherapy with peripheral blood progenitor cell support for advanced breast cancer

      ONCOLOGY REPORTS
    32. Feyerabend, T; Wiedemann, GJ; Steeves, R
      Advanced non-seminomatous germ cell cancer of the testis with brain metastases: Feasibility of additional brain irradiation and whole body hyperthermia plus chemotherapy

      ONCOLOGY REPORTS
    33. Higashiyama, M; Kodama, K; Yokouchi, H; Takami, K; Nakagawa, H; Imamura, F; Minamigawa, K; Kobayashi, H
      Cisplatin-based chemotherapy for postoperative recurrence in non-small cell lung cancer patients: Relation of the in vitro chemosensitive test to clinical response

      ONCOLOGY REPORTS
    34. Adachi, S; Ogasawara, T; Ito, K; Koyama, M; Nagano, T; Suzuki, A; Yamada, T; Nakata, Y; Ozawa, M
      A pilot study of paclitaxel and carboplatin for recurrent ovarian cancer

      ONCOLOGY REPORTS
    35. Bretti, S; Manzin, E; Celano, A; Ritorto, G; Loddo, C; Berruti, A
      Low dose carboplatin (AUC 4.5) combined with vinorelbine in the treatment of advanced non-small cell lung cancer: A single institution phase II study

      ONCOLOGY REPORTS
    36. Adachi, S; Itani, Y; Ito, K; Noda, T; Shintani, M; Saito, K; Furukawa, N; Tomii, Y
      Prognostic results of cisplatin IP and carboplatin IV with G-CSF in patients with ovarian cancer

      ONCOLOGY REPORTS
    37. Sommer, K; Peters, SO; Robins, IH; Raap, M; Wiedemann, GJ; Remmert, S; Sieg, P; Bittner, C; Feyerabend, T
      A preclinical model for experimental chemotherapy of human head and neck cancer

      INTERNATIONAL JOURNAL OF ONCOLOGY
    38. Bowers, DC; Krause, TP; Aronson, LJ; Barzi, A; Burger, PC; Carson, BS; Weingart, JD; Wharam, MD; Melhem, ER; Cohen, KJ
      Second surgery for recurrent pilocytic astrocytoma in children

      PEDIATRIC NEUROSURGERY
    39. Guven, K; Kittler, H; Wolff, K; Pehamberger, H
      Cisplatin and carboplatin combination as second-line chemotherapy in dacarbazine-resistant melanoma patients

      MELANOMA RESEARCH
    40. Westermann, AM; Grosen, EA; Katschinski, DM; Jager, D; Rietbroek, R; Schink, JC; Tiggelaar, CL; Jager, E; Vording, PZVS; Neuman, A; Knuth, A; Van Dijk, JDP; Wiedemann, GJ; Robins, HI
      Pilot study of whole body hyperthermia and carboplatin in platinum-resistant ovarian cancer

      EUROPEAN JOURNAL OF CANCER
    41. Bellmunt, J; de Wit, R; Albanell, J; Baselga, J
      A feasibility study of carboplatin with fixed dose of gemcitabine in 'unfit' patients with advanced bladder cancer

      EUROPEAN JOURNAL OF CANCER
    42. Garattini, S; La Vecchia, C
      Perspectives in cancer chemotherapy

      EUROPEAN JOURNAL OF CANCER
    43. Schellens, JHM; Planting, AST; Ma, J; Maliepaard, M; de Vos, A; Dennert, MD; Verweij, J
      Adaptive intrapatient dose escalation of cisplatin in patients with advanced head and neck cancer

      ANTI-CANCER DRUGS
    44. Waltmire, CN; Alberts, DS; Dorr, RT
      Sequence-dependent cytotoxicity of combination chemotherapy using paclitaxel, carboplatin and bleomycin in human lung and ovarian cancer

      ANTI-CANCER DRUGS
    45. Green, MR
      The current status of docetaxel for advanced non-small cell lung cancer

      ANTI-CANCER DRUGS
    46. Piccart, MJ; Lamb, H; Vermorken, JB
      Current and future potential roles of the platinum drugs in the treatment of ovarian cancer

      ANNALS OF ONCOLOGY
    47. Skarlos, DV; Samantas, E; Briassoulis, E; Panoussaki, E; Pavlidis, N; Kalofonos, HP; Kardamakis, D; Tsiakopoulos, E; Kosmidis, P; Tsavdaridis, D; Tzitzikas, J; Tsekeris, P; Kouvatseas, G; Zamboglou, N; Fountzilas, G
      Randomized comparison of early versus late hyperfractionated thoracic irradiation concurrently with chemotherapy in limited disease small-cell lung cancer: A randomized phase II study of the Hellenic Cooperative Oncology Group (HeCOG)

      ANNALS OF ONCOLOGY
    48. du Bois, A; Luck, HJ; Pfisterer, J; Schroeder, W; Blohmer, JU; Kimmig, R; Moebus, V; Quaas, J
      Second-line carboplatin and gemcitabine in platinum sensitive ovarian cancer - a dose-finding study by the Arbeitsgemeinschaft Gynakologische Onkologie (AGO) Ovarian Cancer Study Group

      ANNALS OF ONCOLOGY
    49. Rick, O; Beyer, J; Schwella, N; Schubart, H; Schleicher, J; Siegert, W
      Assessment of amifostine as protection from chemotherapy-induced toxicities after conventional-dose and high-dose chemotherapy in patients with germ cell tumor

      ANNALS OF ONCOLOGY
    50. Shannon, C; Crombie, C; Brooks, A; Lau, H; Drummond, M; Gurney, H
      Carboplatin and gemcitabine in metastatic transitional cell carcinoma of the urothelium: Effective treatment of patients with poor prognostic features

      ANNALS OF ONCOLOGY
    51. Quoix, E; Breton, JL; Daniel, C; Jacoulet, P; Debieuvre, D; Paillot, N; Kessler, R; Moreau, L; Coetmeur, D; Lemarie, E; Milleron, B
      Etoposide phosphate with carboplatin in the treatment of elderly patients with small-cell lung cancer: A phase II study

      ANNALS OF ONCOLOGY
    52. van Putten, JWG; Kerbush, T; Smit, EF; van Rijswijk, R; Beijnen, JH; Sleijfer, DT; Groen, HJM
      Dose-finding and pharmacological study of ifosfamide in combination with paclitaxel and carboplatin in resistant small-cell lung cancer

      ANNALS OF ONCOLOGY
    53. Aebi, S; Castiglione-Gertsch, M
      High-dose chemotherapy for ovarian cancer: Are we ready to go?

      ANNALS OF ONCOLOGY
    54. Berghmans, T; Paesmans, M; Sculier, JP
      The role of cisplatin in the treatment of small-cell lung cancer?

      ANNALS OF ONCOLOGY
    55. Ledermann, JA; Herd, R; Maraninchi, D; Viens, P; Buclon, M; Philip, T; Cure, H; Lotz, JP; Chauvin, F; Ferrante, P; Rosti, G
      High-dose chemotherapy for ovarian carcinoma: Long-term results from the Solid Tumour Registry of the European Group for Blood and Marrow Transplantation (EBMT)

      ANNALS OF ONCOLOGY
    56. Hansen, HH; Daugaard, G
      Management of carcinoma of unknown primary site (CUP), any changes?

      ANNALS OF ONCOLOGY
    57. Mavroudis, D; Papadakis, E; Veslemes, M; Tsiafaki, X; Stavrakakis, J; Kouroussis, C; Kakolyris, S; Bania, E; Jordanoglou, J; Agelidou, M; Vlachonicolis, J; Georgoulias, V
      A multicenter randomized clinical trial comparing paclitaxel-cisplatin-etoposide versus cisplatin-etoposide as first-line treatment in patients with small-cell lung cancer

      ANNALS OF ONCOLOGY
    58. Dunphy, FR; Dunleavy, TL; Harrison, BR; Cantrell, CL; Visconti, JL; Pincus, SM; Richart, JM; Petruska, PJ
      Phase I dose escalation study of topotecan combined with alternating schedules of paclitaxel and carboplatin in advanced solid tumors

      ANNALS OF ONCOLOGY
    59. Kakolyris, S; Mavroudis, D; Tsavaris, N; Souglakos, J; Tsiafaki, P; Kalbakis, K; Agelaki, S; Androulakis, N; Georgoulias, V
      Paclitaxel in combination with carboplatin as salvage treatment in refractory small-cell lung cancer (SCLC): A multicenter phase II study

      ANNALS OF ONCOLOGY
    60. Brada, M; Hoang-Xuan, K; Rampling, R; Dietrich, PY; Dirix, LY; Macdonald, D; Heimans, JJ; Zonnenberg, BA; Bravo-Marques, JM; Henriksson, R; Stupp, R; Yue, N; Bruner, J; Dugan, M; Rao, S; Zaknoen, S
      Multicenter phase II trial of temozolomide in patients with glioblastoma multiforme at first relapse

      ANNALS OF ONCOLOGY
    61. Sumi, H; Itoh, K; Onozawa, Y; Shigeoka, Y; Kodama, K; Ishizawa, K; Fujii, H; Minami, H; Igarashi, T; Sasaki, Y
      Treatable subsets in cancer of unknown primary origin

      JAPANESE JOURNAL OF CANCER RESEARCH
    62. Matsumoto, M; Takeda, Y; Maki, H; Hojo, K; Wada, T; Nishitani, Y; Maekawa, R; Yoshioka, T
      Preclinical in vivo antitumor efficacy of nedaplatin with gemcitabine against human lung cancer

      JAPANESE JOURNAL OF CANCER RESEARCH
    63. Curis, E; Provost, K; Bouvet, D; Nicolis, I; Crauste-Manciet, S; Brossard, D; Benazath, S
      Carboplatin and oxaliplatin decomposition in chloride medium, monitored byXAS.

      JOURNAL OF SYNCHROTRON RADIATION
    64. Coleman, M; Leonard, J; Shuster, MW; Kaufman, TP
      DICE (dexamethasone, ifosfamide, cisplatin, etoposide) infusional chemotherapy for refractory or relapsed non-Hodgkin's lymphoma (NHL)

      EUROPEAN JOURNAL OF HAEMATOLOGY
    65. Kingreen, D; Beyer, J; Kleiner, S; Reif, S; Huhn, D; Siegert, W
      ICE - an efficient drug combination for stem cell mobilization and high-dose treatment of malignant lymphoma

      EUROPEAN JOURNAL OF HAEMATOLOGY
    66. Ferlini, C; Distefano, M; Pierelli, L; Bonanno, G; Fattorossi, A; Battaglia, A; Mancuso, S; Scambia, G
      A new method to evaluate in vitro myelotoxicity of antitumour agents in the first steps of drug development

      PHARMACOLOGY & TOXICOLOGY
    67. Gandara, DR; Edelman, MJ; Lara, PN; Lau, DHM
      Gemcitabine in combination with new platinum compounds: An update

      ONCOLOGY-NEW YORK
    68. Nagourney, RA
      Gemcitabine plus cisplatin in breast cancer

      ONCOLOGY-NEW YORK
    69. Markman, M
      Is there a role for intraperitoneal chemotherapy in the management of ovarian cancer?

      ONCOLOGY-NEW YORK
    70. Amatuzzi, MG; Northrop, C; Liberman, MC; Thornton, A; Halpin, C; Herrmann, B; Pinto, LE; Saenz, A; Carranza, A; Eavey, RD
      Selective inner hair cell loss in premature infants and cochlea pathological patterns from neonatal intensive care unit autopsies

      ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY
    71. Lebeau, B; Urban, T; Baud, M; Collon, T; Le Guen, Y; Febvre, M; Touboul, E
      Chemoradiotherapy-chemotherapy for grade III inoperable non-small-cell lung cancer

      REVUE DES MALADIES RESPIRATOIRES
    72. Edmonson, JH; Suman, VJ; Dalton, RJ; Bro, WC; Gallenberg, MM; Long, HJ; Levitt, R; Hatfield, AK; Krook, JE; Mailliard, JA; Gerstner, JB
      Comparison of conventional dose and double dose carboplatin in patients receiving cyclophosphamide plus carboplatin for advanced ovarian carcinoma: Anorth central cancer treatment group study

      CANCER INVESTIGATION
    73. Kastrissios, H; Ratain, MJ
      Screening for sources of interindividual pharmacokinetic variability in anticancer drug therapy: Utility of population analysis

      CANCER INVESTIGATION
    74. Mazumdar, M; Bajorin, DF; Bacik, J; Higgins, G; Motzer, RJ; Bosl, GJ
      Predicting outcome to chemotherapy in patients with germ cell tumors: The value of the rate of decline of human chorionic gonadotrophin and alpha-fetoprotein during therapy

      JOURNAL OF CLINICAL ONCOLOGY
    75. Fountzilas, G; Papadimitriou, C; Dafni, U; Bafaloukos, D; Skarlos, D; Moulopouos, LA; Razis, E; Kalofonos, HP; Aravantinos, G; Briassoulis, E; Papakostas, P; Abela, K; Gogas, E; Kosmidis, P; Pavlidis, N; Dimopoulos, MA
      Dose-dense sequential chemotherapy with epirubicin and paclitaxel versus the combination, as first-line chemotherapy, in advanced breast cancer: A randomized study conducted by the Hellenic Cooperative Oncology Group

      JOURNAL OF CLINICAL ONCOLOGY
    76. Hartmann, JT; Einhorn, L; Nichols, CR; Droz, JP; Horwich, A; Gerl, A; Fossa, SD; Beyer, J; Pont, J; Schmoll, HJ; Kanz, L; Bokemeyer, C
      Second-line chemotherapy in patients with relapsed extragonadal nonseminomatous germ cell tumors: Results of an international multicenter analysis

      JOURNAL OF CLINICAL ONCOLOGY
    77. Doyle, C; Crump, M; Pintilie, M; Oza, AM
      Does palliative chemotherapy palliate? Evaluation of expectations, outcomes, and costs in women receiving chemotherapy for advanced ovarian cancer

      JOURNAL OF CLINICAL ONCOLOGY
    78. Isla, D; Rosell, R; Sanchez, JJ; Carrato, A; Felip, E; Camps, C; Artal, A; Gonzalez-Larriba, JL; Azagra, P; Alberola, J; Martin, C; Massuti, B
      Phase II trial of paclitaxel plus gemcitabine in patients with locally advanced or metastatic non-small-cell lung cancer

      JOURNAL OF CLINICAL ONCOLOGY
    79. Vuky, J; Bains, M; Bacik, J; Higgins, G; Bajorin, DF; Mazumdar, M; Bosl, GJ; Motzer, RJ
      Role of postchemotherapy adjunctive surgery in the management of patients with nonseminoma arising from the mediastinum

      JOURNAL OF CLINICAL ONCOLOGY
    80. Monnet, I; Soulie, P; de Cremoux, H; Saltiel-Voisin, S; Bekradda, M; Saltiel, JC; Brain, E; Dupont-Andre, G; Cvitkovic, E
      Phase I/II study of escalating doses of vinorelbine in combination with oxaliplatin in patients with advanced non-small-cell lung cancer

      JOURNAL OF CLINICAL ONCOLOGY
    81. Bremnes, RM; Sundstrom, S; Vilsvik, J; Aasebo, U
      Multicenter phase II trial of paclitaxel, cisplatin, and etoposide with concurrent radiation for limited-stage small-cell lung cancer

      JOURNAL OF CLINICAL ONCOLOGY
    82. Meluch, AA; Greco, FA; Burris, HA; O'Rourke, T; Ortega, G; Steis, RG; Morrissey, LH; Johnson, V; Hainsworth, JD
      Paclitaxel and gemcitabine chemotherapy for advanced transitional-cell carcinoma of the urothelial tract: A phase II trial of the Minnie Pearl CancerResearch Network

      JOURNAL OF CLINICAL ONCOLOGY
    83. Sternberg, CN; de Mulder, PHM; Schornagel, JH; Theodore, C; Fossa, SD; van Oosterom, AT; Witjes, F; Spina, M; van Groeningen, CJ; de Balincourt, C; Collette, L
      Randomized phase III trial of high-dose-intensity methotrexate, vinblastine, doxorubicin, and cisplatin (MVAC) chemotherapy amd recombinant human granulocyte colony-stimulating factor versus classic MVAC in advanced urothelial tract tumors: European organization for research and treatment of cancerprotocol no. 30924

      JOURNAL OF CLINICAL ONCOLOGY
    84. Kosmas, C; Tsavaris, NB; Malamos, NA; Vadiaka, M; Koufos, C
      Phase II study of paclitaxel, ifosfamide, and cisplatin as second-line treatment in relapsed small-cell lung cancer

      JOURNAL OF CLINICAL ONCOLOGY
    85. Albers, P; Perabo, FGE; Melchior, D; Siener, R
      Adjuvant chemotherapy in stage I and stage II testicular cancer

      WORLD JOURNAL OF UROLOGY
    86. Recchia, F; De Filippis, S; Rosselli, M; Saggio, G; Carta, G; Rea, S
      Primary chemotherapy in stage IV ovarian cancer. A prospective phase II study

      EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY
    87. Trope, C; Kristensen, G; Kisic, J; Kaern, J
      Long-term results from a phase II study of paclitaxel combined with doxorubicin in recurrent platinum refractory ovarian cancer

      EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY
    88. Topuz, E; Eralp, Y; Saip, P; Aydiner, A; Tas, F; Salihoglu, Y; Berkman, S; Bengisu, E
      The efficacy of combination chemotherapy including intraperitoneal cisplatinum and mitoxantrone with intravenous ifosfamide in patients with FIGO stage IC ovarian carcinoma

      EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY
    89. Kanda, Y; Matsumura, T; Maki, K; Matsuyama, T; Chiba, S; Hirai, H
      Fatal cardiac toxicity in two patients receiving same-day administration of cyclophosphamide and cytarabine as conditioning for hematopoietic stem cell transplantation

      HAEMATOLOGICA
    90. Takizawa, M; Fukuda, S; Yokohama, M; Miyatake, Y; Inuyama, Y
      An experimental study of the combined effect of radiotherapy and chemotherapy on head and neck squamous cell carcinoma cell line

      AURIS NASUS LARYNX
    91. Sawada, S; Mori, N; Mount, RJ; Harrison, RV
      Differential vulnerability of inner and outer hair cell systems to chronicmild hypoxia and glutamate ototoxicity: Insights into the cause of auditory neuropathy

      JOURNAL OF OTOLARYNGOLOGY
    92. Yokoyama, Y; Kaji, H; Kondoh, H; Takeuchi, E; Yamasaki, Y; Inui, Y
      Complete response of a stage IV mucinous cystadenocarcinoma of the ovary to systemic chemotherapy employing paclitaxel and carboplatin

      GYNECOLOGIC AND OBSTETRIC INVESTIGATION
    93. Husain, K; Whitworth, C; Somani, SM; Rybak, LP
      Carboplatin-induced oxidative stress in rat cochlea

      HEARING RESEARCH
    94. Reyes, S; Ding, DL; Sun, W; Salvi, R
      Effect of inner and outer hair cell lesions on electrically evoked otoacoustic emissions

      HEARING RESEARCH
    95. Phillips, DP; Hall, SE; Guo, Y; Burkard, R
      Sensitivity of unanesthetized chinchilla auditory system to noise burst onset, and the effects of carboplatin

      HEARING RESEARCH
    96. Husain, K; Scott, RB; Whitworth, C; Somani, SM; Rybak, LP
      Dose response of carboplatin-induced hearing loss in rats: antioxidant defense system

      HEARING RESEARCH
    97. Akiyama, Y; Ohe, Y; Tamura, T; Sawada, M; Inoue, A; Kusaba, H; Yamamoto, N; Sekine, I; Kunitoh, H; Kodama, T; Saijo, N
      A dose escalation study of paclitaxel and carboplatin in untreated Japanese patients with advanced non-small cell lung cancer

      JAPANESE JOURNAL OF CLINICAL ONCOLOGY
    98. Barone, S; Baer, MR; Sait, SNJ; Lawrence, D; Block, AW; Wetzler, M
      High-dose cytosine arabinoside and idarubicin treatment of chronic myeloidleukemia in myeloid blast crisis

      AMERICAN JOURNAL OF HEMATOLOGY
    99. Blackstock, AW; Lesser, GJ; Fletcher-Steede, J; Case, LD; Tucker, RW; Russo, SM; White, DR; Miller, A
      Phase I study of twice-weekly gemcitabine and concurrent thoracic radiation for patients with locally advanced non-small-cell lung cancer

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    100. Jeremic, B; Shibamoto, Y; Acimovic, L; Milicic, B; Milisavljevic, S; Nikolic, N; Dagovic, A; Aleksandrovic, J; Radosavljevic-Asic, G
      Hyperfractionated radiation therapy and concurrent low-dose, daily carboplatin/etoposide with or without weekend carboplatin/etoposide chemotherapy in stage III non-small-cell lung cancer: A randomized trial

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 05/06/20 alle ore 15:48:44